Education; providing of training; research in the field of education; entertainment; arranging and conducting of events and training activities using the arts for recreational, cultural, educational and entertainment purposes; arranging and conducting of academic enrichment programs and of educational studies, protocols and research aimed at improving leadership, transfer of business knowledge and know-how [training], vocational guidance [education or training advice], retraining, lifestyle counselling [health and training], and providing of training and instruction in the field of well-being; academies [education]; teaching and instruction services; post graduate and executive education; publication of books; arranging and conducting of courses, masterclasses, colloquiums, conferences, congresses, seminars, symposiums, workshops, master's programs, and of educational mentoring services in all fields of study relevant to the theory and practice of leadership development and human flourishing; provision of personal assessment services for training, developmental and educational certification; services for the entertainment, amusement or recreation of people.

Biologics, namely cells and cell lines for use in the development, testing and manufacture of therapeutics; biologics, namely cells and cell lines for use in the production of biologic substances, namely, growth factors and proteins; biologics, namely cells and cell lines for the testing of chemical substances; stem cells and progenitor cells for use in the development, testing and manufacture of therapeutics; stem cells and progenitor cells for the testing of chemical substances; bone marrow stromal cells (BMSCs) for use in the development, testing and manufacture of therapeutics; bone marrow stromal cells (BMSCs) for use in the production of biologic substances, namely, growth factors and proteins; bone marrow stromal cells (BMSCs) for the testing of chemical substances; adipose tissue stromal cells (ASCs) for use in the development, testing and manufacture of therapeutics; adipose tissue stromal cells (ASCs) for use in the production of biologic substances, namely, growth factors and proteins; adipose tissue stromal cells (ASCs) for the testing of chemical substances

Biologics, namely cells and cell lines for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, particularly against pathogens or cancers, or to modulate the immune system, particularly against auto-immune disease or inflammatory conditions; stem cells and progenitor cells for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, particularly against pathogens or cancers, or to modulate the immune system, particularly against auto-immune disease or inflammatory conditions; bone marrow stromal cells (BMSCs) for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, particularly against pathogens or cancers, or to modulate the immune system, particularly against auto-immune disease or inflammatory conditions; adipose tissue stromal cells (ASCs) for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, particularly against pathogens or cancers, or to modulate the immune system, particularly against auto-immune disease or inflammatory conditions; cell growth media consisting of biological materials for growing cells for medical purposes; stem cells and progenitor cells for use in the production of biologic substances, namely, growth factors and proteins for medical purposes; proteins for medical use, namely, protein arrays for medical diagnosis purposes; synthetic peptides for medical purposes, namely, the treatment of neuro-degenerative disorders, metabolic disorders, inflammatory and auto-immune disorders, orthopedic disorders, heart and vasculature disorders, and cancer; small molecules for medical purposes, namely, clinical diagnostic reagents; telomerase activators (agonists) and inhibitors (antagonists) for use as medicinal products; cell-based therapeutics for the treatment of central nervous system (CNS) disorders, de-myelinating disorders, auto-immune disorders, peripheral neural disorders, namely, Guillain-Barre Strohl Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy (CIPD), Diabetic Neuropathy, Peripheral Nerve Injuries, Radiculopathies, and Small Fiber Neuropathies, and autism; Cell-based therapeutics for the treatment of stroke, spinal cord injury, brain injury, brain tumours, Amyotrophic Lateral Sclerosis (ALS) (Lou Gehrig's Disease), Parkinson's disease, Huntington's disease, Multiple Sclerosis (MS), and MS-like diseases with the following symptoms: cognitive dysfunction, mobility dysfunction, and neurological disorders; Pharmaceutical preparations for the treatment of the central nervous system (CNS), namely stroke, spinal cord injury, brain injury, brain tumours, amyotrophic lateral sclerosis (ALS) (Lou Gehrig's Disease), Parkinson's disease, Huntington's disease, multiple sclerosis (MS), and cognitive dysfunction, mobility dysfunction, and neurological disorders, peripheral neural disorders, namely, Guillain-Barre Strohl Syndrome, Chronic Inflammatory Demyelinating Polyneuropathy (CIPD), Diabetic Neuropathy, Peripheral Nerve Injuries, Radiculopathies, and Small Fiber Neuropathies, and autism

Magazine publication comprising news and information concerning the oil and gas industry.

(1) Biologics, namely Cells and cell lines for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, including against pathogens or cancers, or to modulate the immune system, including against auto-immune disease or inflammatory conditions (2) Stem cells and progenitor cells for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, including against pathogens or cancers, or to modulate the immune system, including against auto-immune disease or inflammatory conditions (3) Bone Marrow Stromal Cells (BMSCs) for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, including against pathogens or cancers, or to modulate the immune system, including against auto-immune disease or inflammatory conditions (4) Adipose tissue stromal cells (ASCs) for use as therapeutics to repair, replace or preserve cells and tissues, or to mobilize the immune system, including against pathogens or cancers, or to modulate the immune system, including against auto-immune disease or inflammatory conditions (5) Growth factors for use as medicinal products (6) Proteins for use as medicinal products (7) Peptides for use as medicinal products , (8) Small molecules for use as medicinal products , (9) Telomerase activators (agonists) and inhibitors (antagonists) for use as medicinal products (10) Cell-based therapeutics for the treatment of Central Nervous System (CNS) disorders, de-myelinating disorders, auto-immune disorders, peripheral neural disorders, and autism (11) Cell-based therapeutics for the treatment of stroke, spinal cord injury, brain injury, brain tumours, Amyotrophic Lateral Sclerosis (ALS) (Lou Gehrig's Disease), Parkinson's disease, Huntington's disease, peripheral neural disorders, autism, Multiple Sclerosis (MS), and MS-like diseases with the following symptoms: cognitive dysfunction, mobility dysfunction, and neurological disorders (12) Pharmaceutical preparations for the treatment of the Central Nervous System (CNS), namely stroke, spinal cord injury, brain injury, brain tumours, Amyotrophic Lateral Sclerosis (ALS) (Lou Gehrig's Disease), Parkinson's disease, Huntington's disease, Multiple Sclerosis (MS), and cognitive dysfunction, mobility dysfunction, and neurological disorders, peripheral neural disorders, and autism (13) Biologics, namely Cells and cell lines for use in the development, testing and manufacture of therapeutics (14) Biologics, namely Cells and cell lines for use in the production of biologic substances, including growth factors and proteins , (15) Biologics, namely Cells and cell lines for the testing of chemical substances (16) Stem cells and progenitor cells for use in the development, testing and manufacture of therapeutics (17) Stem cells and progenitor cells for use in the production of biologic substances, including growth factors and proteins (18) Stem cells and progenitor cells for the testing of chemical substances , (19) Bone Marrow Stromal Cells (BMSCs) for use in the development, testing and manufacture of therapeutics (20) Bone Marrow Stromal Cells (BMSCs) for use in the production of biologic substances, including growth factors and proteins (21) Bone Marrow Stromal Cells (BMSCs) for the testing of chemical substances (22) Adipose tissue stromal cells (ASCs) for use in the development, testing and manufacture of therapeutics (23) Adipose tissue stromal cells (ASCs) for use in the production of biologic substances, including growth factors and proteins (24) Adipose tissue stromal cells (ASCs) for the testing of chemical substances.

(1) Pharmaceutical research, development and medical treatment services (2) Biological research, development and medical treatment services (3) Medical research, development and medical treatment services (including regenerative medicine and immunotherapies) (4) Consultation, research and treatment in the field of stem and progenitor cells and bone marrow stromal cells and adipose tissue stromal cells (5) Consultation, research and treatment in the field of Central Nervous System (CNS) disorders , (6) Consultation, research and treatment in the field of stroke, spinal cord injury, brain injury, brain tumours, Amyotrophic Lateral Sclerosis (ALS) (Lou Gehrig's Disease), Parkinson's Disease, Huntington's Disease, Multiple Sclerosis (MS), and MS-like diseases, peripheral neural disorders, and autism (7) Research and development of, and treatment with, cell-based therapies for the treatment of neurological and Central Nervous System (CNS) injuries and disorders, de-myelinating disorders, auto-immune disorders, peripheral neural disorders, and autism (8) Manufacturing of biologics, cells, scaffolds and matrices, and related biological materials.

Performance of research services in the development of cellular products in the field of neural cell implants